Skip to main content
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Stephen Taub
Latest Articles
Premium
Tiger Cubs Cash In as Stripe’s Valuation Takes Off
Stephen Taub
February 25, 2026
Premium
Caxton’s U.S. Stock Book Jumps 40 Percent as Law Adds Three New Mega Positions
Stephen Taub
February 24, 2026
Premium
CTAs Surge Ahead of Equity Markets as Metals‑Driven Trends Fuel January Gains
Stephen Taub
February 23, 2026
Premium
Stan Druckenmiller Piles Into Financials and Brazil as Health-Care Bets Fade
Stephen Taub
February 19, 2026
Premium
Lone Pine Offloads Meta in Rare One‑Quarter Exit
Stephen Taub
February 18, 2026
Maverick’s New Top Positions Deliver Both Gains and Setbacks
Stephen Taub
February 17, 2026
Biopharma Hedge Funds Stumble as Last Year’s Rally Fades
Stephen Taub
February 12, 2026
Premium
Light Street’s New Long Game
Stephen Taub
February 11, 2026
Premium
Viking Hybrid Fund Gains in the Fourth Quarter as Private Investment Strategy Slips
Stephen Taub
February 10, 2026
Premium
Third Point Overhauls Its Top Holdings in an Unusual Shake-Up
Stephen Taub
February 9, 2026
Premium
Haidar Kicks Off the Year With a Big Jump as Discovery Builds on Its Multi‑Year Tear
Stephen Taub
February 5, 2026
‘AI Supercycle Is Here to Stay’: Light Street Posts Strong January Returns as It Revamps Tech Strategy
Stephen Taub
February 4, 2026
A Unicorn IPO Wave Could Deliver Windfalls for Hedge Funds
Stephen Taub
February 3, 2026
Premium
Bearish but Booming, David Einhorn’s Greenlight Starts 2026 With a Win
Stephen Taub
February 2, 2026
Premium
With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma
Stephen Taub
January 29, 2026
Premium
The Tiger Grandcub Who Outsmarted the AI Frenzy
Stephen Taub
January 28, 2026
How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year
Stephen Taub
January 27, 2026
Premium
The Lowdown on High Ground’s Best Year
Stephen Taub
January 26, 2026
More Articles